Fiscal year 24 toxic exposures research program
Ended Awarded Last action
- Contract number
- HT942524F0218
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $135,509
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 100% obligated
- $135,509.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $6,051 | |
| Original award | $129,458 |
About this award
The Defense Health Agency awarded a delivery order valued at $135.5K to Leidos, Inc. (operating as SAIC) on September 30, 2024, under the Fiscal Year 24 Toxic Exposures Research Program. This cost-plus-fixed-fee contract, which has no set-aside designation, is scheduled for completion by July 13, 2025, and will be performed in Herndon, Virginia. The delivery order supports the Defense Health Agency's research initiatives focused on toxic exposure effects and mitigation, contributing to the broader federal effort to understand and address health impacts from environmental and occupational hazard exposures affecting military personnel and the defense community.
Leidos, Inc., a large global technology and engineering solutions provider headquartered in Reston, Virginia, brings substantial experience in medical research and health-focused contracts to this engagement. The company's extensive portfolio with the Defense Health Agency and other medical research-focused federal agencies—including the National Cancer Institute and National Institute of Allergy and Infectious Diseases—positions it well to support toxic exposure research initiatives. As a child entity of Leidos Holdings, Inc., the company operates through its Leidos Services Operating Segment (doing business as SAIC) and typically engages subcontractors to deliver comprehensive technical solutions on complex government research programs.
Quick answers
Who was awarded contract HT942524F0218?
HT942524F0218 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on September 30, 2024.
How much is contract HT942524F0218 worth?
The government has obligated $135,509 on HT942524F0218.
Is contract HT942524F0218 an order under another contract?
Yes. HT942524F0218 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942524F0218 competed?
The extent of competition for HT942524F0218 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award